title: [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
abstract: BACKGROUND
  The vaccination of health workers has a large repercussion on the health of the workers, the patients and the population in general. Due to this, we proposed to discover the serological status for varicella, rubella, mumps and measles in the workers of a tertiary hospital in Madrid.
  
  
  METHODS
  We have conducted a retrospective epidemiological study of 1060 health workers, obtaining information such as age, sex, service area, employment status, pre-exposure vaccination and post-vaccination serology and vaccination status.
  
  
  RESULTS
  In the population studied, 90.1% were protected against varicella, 65.6% against mumps, 95.6% against rubella and 92.9% against measles. There is no better protection against these illnesses for workers who treat patients directly, workers who treat immunosuppressed patients or for workers in services or units with a higher risk of infection.
  
  
  CONCLUSIONS
  There is no better protection against varicella, rubella, mumps and measles for the workers who have higher risk of infection at work; and the workers who treat patients, that if they suffer these diseases, this could put their health at risk.
authors.affiliation: Maria Luisa Rodríguez de la Pinta. Servicio de Prevención de Riesgos Laborales. Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquín Rodrigo Nº 2, 28220 Majadahonda, Madrid, Spain. mrpinta@salud.madrid.org.
authors.forename: Ma Luisa
authors.initials: ML
authors.lastname: Rodríguez
authors.forename: David
authors.initials: D
authors.lastname: Martínez
authors.forename: Juana Maria
authors.initials: JM
authors.lastname: Santos-Sancho
authors.forename: Jenry Ricardo
authors.initials: JR
authors.lastname: Borda
authors.forename: Ana
authors.initials: A
authors.lastname: Orero
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D002644:Chickenpox / Q000453:epidemiology* / Q000517:prevention & control; D019433:Chickenpox Vaccine; D005260:Female; D006282:Health Personnel / Q000706:statistics & numerical data*; D006748:Hospital Departments; D006801:Humans; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control; D022542:Measles-Mumps-Rubella Vaccine; D008875:Middle Aged; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control; D016273:Occupational Exposure; D012189:Retrospective Studies; D012409:Rubella / Q000453:epidemiology* / Q000517:prevention & control; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology; D062606:Tertiary Care Centers; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D000914:Antibodies, Viral; D019433:Chickenpox Vaccine; D022542:Measles-Mumps-Rubella Vaccine